• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1998 Fiscal Year Final Research Report Summary

ANALYSES OF EXOCYTOSIS SPECIFIC TO GROWTH FACTORS THAT HAVE NO SECRETION SIGNALS

Research Project

Project/Area Number 09650879
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 生物・生体工学
Research InstitutionOKAYAMA UNIVERSITY

Principal Investigator

SENO Masaharu  FACULTY OF ENGINEERING,OKAYAMA UNIVERSITY ASSOCIATE PROFESSOR, 工学部, 助教授 (90243493)

Co-Investigator(Kenkyū-buntansha) TADA Hiroko  FACULTY OF ENGINEERING,OKAYAMA UNIVERSITY INSTRUCTOR, 工学部, 助手 (60271061)
YAMADA Hidenori  FACULTY OF ENGINEERING,OKAYAMA UNIVERSITY PROFESSOR, 工学部, 教授 (80037613)
Project Period (FY) 1997 – 1998
KeywordsSECRETION SIGNAL / GROWTH FACTOR / EXOCYTOSIS / SOLUBLE RECEPTOR / FIBROBLAST GROWTH FACTOR / CRIPTO
Research Abstract

The mechanism of the transport from inside to outside of the cells are analyzed on basic fibroblast growth factor (bFGF) and Cripto (CR-I) because these two growth factors have been suggested not to have representative secretion signals and exocytosis of these molecules have not been elucidated.
First of all, bFGF was co-expressed with its soluble receptor in mouse fibroblast cell line BALB/c 3T3 by transfecting these two genes. And we found these transformants secreting bFGF molecule into the culture medium only when the soluble receptor co-expressed. Furthermore the transformant expressing both bFGF and soluble receptor showed high tumorigenicity in nude mice. These results strongly suggest that the exocytosis of bFGF is dependent on the presence of soluble receptors.
CR-l, which is a novel member of epidermal growth factor (EGF) family, has been characterized in various ways. Recombinant expression of CR-l in mammalian cells showed heterogeneous molecular weight of 20, 22, 24, and 28 Kd in Western blotting analyses. On the other hand, a specy of 18 Kd appeared in majority in the presence of tunicamycin which blocked the N-glycosilation of the site in the EGF motif of CR-l. This result is consistent with the cleaved size of CR-l peptide at the site theoretically predicted for secretion signal. However, the CR-l aminoterminally truncated by 36 mino acid residues was found to be secreted from the cells when the mutant gene was transfected to mammalian cell lines such as COS7 or CHO.This suggests that CR-l undergoes the pathway of exocytosis independent of the secretion signals. Together with the recent findings that CR-l related peptides are essentially involved in the development of embryos, characterization of CR- l is getting more important than ever.

  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] Subha Kannan: "Cripto enhances the tyrosine phosphorylation of shc and activates MAP kinase in mammary epithelial cells." J.Biol.Chem.272・6. 3330-3335 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Junichiro Futami: "Tissue specific expression of pancreatic-type RNases and RNase inhibitor in humans." DNA Cell Biol.16・4. 413-419 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 古川 恵: "TGF-βスーパーファミリーのメンバーによる膵内分泌細胞の分化誘導." PEPTIDE HORMONES IN PANCREAS. 17. 55-58 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Masakazu Ueda: "Molecular Targeting for Epidermal Growth Factor Receptor Expressed on Breast Cancer Cells." Breast Cancer. 4・4. 67-69 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Marta DeSantis: "Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras- and phosphatidylinositol 3′-kinase dependent pathway." Cell Growth Differ.8・12. 1257-1266 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Masaharu Seno: "Biological activities of a recombinant human Cripto-1 protein." Cell Struct.Funct.22・6. 803-803 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Masaharu Seno: "Purification and Characterization of a Recombinant Human Cripto-1 Protein." Growth Factors. 15・3. 215-229 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Masaharu Seno: "BALB/c3T3 cells co-expressing FGF-2 and soluble FGF receptor acquire tumorigenicity." Cytokine. 10・4. 290-294 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Junzo Sasaki: "Multiple-labeling of oligonucleotide probes for in situ hybridization." Acta Histochem.Cytochem.31・4. 275-279 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kyriakos Psarras: "Human pancreatic RNase1-human epidermal growth factor fusion : an entirely human 'immunotoxin analog' with cytotoxic properties against squamous cell carcinomas." Protein Eng.11・12. 1285-1292 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ishiyama N.: "Studies on the betacellulin receptor in pancreatic AR42J cells." Diabetologia. 41・6. 623-628 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Simon S.Terzyn: "The three dimensional structure of human RNase4, unliganded and complexed with d(Up), reveals the basis for its uridine selectivity." J.Mol.Biol.285・1. 205-214 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Subha Kannan: "Cripto enhances the tyrosine phosphorylation of shc and activates MAP kinase in mammary epithelial cells" J.Biol.Chem.272 (6). 3330-3335 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Junichiro Futami: "Tissue specific expression of pancreatic-type RNases and RNase inhibitor in humans" DNA Cell Biol.16 (4). 413-419 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Megumi Furukawa: "Induction of cellular differentiation in pancreatic endocrine cells with TGF-beta family" PEPTIDE HORMONES IN PANCREAS. 17. 55-58 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Masakazu Ueda: "Molecular Targeting for Epidermal Growth Factor Receptor Expressed on Breast Cancer Cells" Breast Cancer. 4 (4). 67-69 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Marta DeSantis: "Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase dependent pathway" Cell Growth Differ. 8 (12). 1257-1266 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Masaharu Seno: "Biological activities of a recombinant human Cripto-1 protein" Cell Struct.Funct.22 (6). 803-803 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Masaharu Seno: "Purification and Characterization of a Recombinant Human Cripto-1 Protein" Growth Factors. 15 (3). 215-229 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Masaharu Seno: "BALB/c3T3 cells co-expressing FGF-2 and soluble FGF receptor acquire tumorigenicity" Cytokine. 10 (4). 290-294 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishiyama, N.: "Studies on the betacellulin receptor in pancreatic AR42J cells" Diabetologia. 41 (6). 623-628 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Junzo Sasaki: "Multiple-labeling of oligonucleotide probes for in situ hybridization" Acta Histochem.Cytochem.31 (4). 275-279 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kyriakos Psarras: "Human pancreatic RNase1-human epidermal growth factor fusion : an entirely human 'immunotoxin analog' with cytotoxic properties against squamous cell carcinomas" Protein Eng.11 (12). 1258-1292 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Simon S.Terzyn: "The three dimensional structure of human RNase4, unliganded and complexed with d (Up), reveals the basis for its uridine selectivity" J.Mol.Biol.285 (1). 205-214 (1999)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-12-08  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi